Close

Ionis Pharma (IONS) Announces Significant Data from IONIS-FXIRx Phase 2 in Patients w/ ESRD on Hemodialysis

Go back to Ionis Pharma (IONS) Announces Significant Data from IONIS-FXIRx Phase 2 in Patients w/ ESRD on Hemodialysis
(NASDAQ: IONS) Delayed: 42.45 +0.61 (1.46%)
Previous Close $41.84    52 Week High $62.68 
Open $41.97    52 Week Low $19.59 
Day High $42.72    P/E N/A 
Day Low $41.59    EPS $0.00 
Volume 728,801